Quarterly ResultMay 8, 2026, 08:12 AM
Azenta Q2 Net Loss $(160.8)M; Goodwill Impairment $149.1M
AI Summary
Azenta, Inc. reported a significant net loss of $(160.8) million for the three months ended March 31, 2026, primarily driven by a $149.1 million impairment of goodwill and intangible assets. This compares to a net loss of $(47.7) million in the same period last year. The company also announced a delay in the divestment of its B Medical Systems business, as the buyer has not yet secured the required financing. Total revenue for the quarter saw a modest increase to $144.8 million from $143.3 million year-over-year.
Key Highlights
- Q2 2026 net loss was $(160.8) million, compared to $(47.7) million in Q2 2025.
- Q2 2026 basic net loss per share was $(3.49), compared to $(1.04) in Q2 2025.
- Total revenue for Q2 2026 was $144.8 million, up from $143.3 million in Q2 2025.
- Impairment of goodwill and intangible assets totaled $149.1 million in Q2 2026.
- Divestment of B Medical Systems business is delayed due to buyer's financing issues.
- Six-month net loss was $(176.2) million, compared to $(58.7) million in prior year.
- Six-month basic net loss per share was $(3.83), compared to $(1.29) in prior year.
- Cash and cash equivalents decreased to $234.0 million from $279.8 million since September 30, 2025.